VALENCIA, Calif., Aug. 25, 2016 -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) announced that the United States District Court for the Central District of California has dismissed the class action that was pending against MannKind Corporation and two of its executives. The Court granted the defendants’ motion to dismiss the plaintiffs’ amended class action complaint without leave to amend, thereby closing the case. The plaintiffs can appeal the decision within 30 days.
ABOUT MANNKIND CORPORATION
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) focuses on the discovery and development of therapeutic products for patients with diseases such as diabetes. MannKind maintains a website at www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.
Company Contact: Rose Alinaya SVP, Finance 661-775-5300 [email protected]


Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit 



